Brandes Investment Partners, Lp - Mar 31, 2025 SCHEDULE 13G Report for AVADEL PHARMACEUTICALS PLC Common Shares (AVDL)

Filing Manager: BRANDES INVESTMENT PARTNERS, LP
Reporting Manager: BRANDES INVESTMENT PARTNERS, LP
Security: AVADEL PHARMACEUTICALS PLC Common Shares
Symbol: AVDL
Shares outstanding: 96.1M shares
Disclosed Ownership: 5.67M shares
Ownership: 5.9%
Form type: SCHEDULE 13G
Date filed: 5/14/2025, 01:14 PM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BRANDES INVESTMENT PARTNERS, LP	5.9%	5.67M	0	3.83M	/s/ Glenn Carlson	Executive Director